EUROIMMUN ChLIA represents the next generation of immunoassay technology, combining speed, sensitivity, and automation to meet the growing demands of modern laboratories. Chemiluminescence immunoassays are highly sensitive detection systems that allow rapid and reliable measurement of antibodies, antigens, and biomarkers in patient samples. By harnessing light-emitting reactions to quantify analytes with precision, ChLIA delivers reproducible results with shorter turnaround times compared to traditional methods. In the Caribbean, EUROIMMUN’s advanced ChLIA solutions are supplied and supported exclusively by Southern Medical Supplies Limited, your trusted partner for diagnostic excellence.
The principle of ChLIA is based on the use of enzyme-labelled conjugates that trigger a luminescent reaction in the presence of specific substrates. The resulting light emission is measured in relative light units (RLUs) by highly sensitive detectors. The intensity of the signal is proportional to the concentration of the analyte in the patient sample, allowing for both qualitative and quantitative evaluation. This technique provides laboratories with a fast, highly sensitive, and scalable diagnostic solution.
EUROIMMUN ChLIA tests cover a wide range of clinical fields, including autoimmune disease diagnostics, infectious disease testing, allergology, endocrinology, Alzheimer’s disease biomarkers, and therapeutic drug monitoring (TDM). This broad test menu allows laboratories to consolidate multiple diagnostic areas into a single technology platform, improving efficiency while ensuring reliable results across diverse patient populations.
One of the defining features of EUROIMMUN ChLIA is its open and flexible test portfolio. Assays are delivered as ready-to-use reagent kits with barcoded vials, ensuring complete traceability, secure handling, and seamless integration into both manual and automated workflows. The test principle is standardized across all parameters, enabling laboratories to streamline processes and minimize training requirements. With its combination of high analytical sensitivity, rapid assay times, and reproducibility, EUROIMMUN ChLIA provides laboratories with confidence for both routine diagnostics and more complex clinical cases.
The advantages of EUROIMMUN ChLIA go beyond speed and sensitivity. Its comprehensive product range spans autoimmune testing, infectious disease diagnostics, allergology, and antigen detection, allowing laboratories to consolidate multiple specialties onto a single platform. Reagents are supplied ready-to-use and pre-barcoded, which guarantees secure tracking and eliminates the risk of handling errors.
Calibration is also simplified. Thanks to stored master curves, calibration requirements are minimal, saving laboratories valuable time and resources while ensuring accuracy. In addition, the systems offer high throughput capacity, with the flexibility to process routine samples and urgent STAT samples side by side, ensuring laboratories can respond quickly to clinical priorities.
Finally, EUROIMMUN ChLIA is designed for seamless automation with EUROIMMUN-compatible analyzers, such as the IDS-iSYS, IDS-i10, and IDS-i20. This ensures laboratories of all sizes can select the right instrument for their throughput needs, while maintaining the same high standards of performance and traceability across every workflow.
EUROIMMUN ChLIA is designed for seamless automation using advanced platforms manufactured by IDS Immunodiagnosticsystems. Laboratories can select from several instruments depending on their throughput needs, ensuring that every facility — from small to high-volume reference centers — can benefit from fast, reliable chemiluminescence immunoassay processing.
The IDS-iSYS is a compact, multi-discipline system that is ideally suited for mid-volume laboratories. It is capable of handling up to 120 samples per hour across multiple diagnostic areas, making it a versatile option for routine workloads that require flexibility without sacrificing speed or reliability.
For laboratories with more dynamic requirements, the IDS-i10 offers higher throughput and flexibility. This random-access analyzer delivers up to 170 tests per hour and features continuous sample loading along with STAT prioritization. These capabilities make it particularly valuable in environments where urgent results are required alongside routine testing.
At the top of the range is the IDS-i20, a next-generation high-capacity analyzer designed for large laboratories managing heavy workloads. It supports the simultaneous processing of up to 20 analytes across six diagnostic specialties and combines exceptional speed with walk-away automation, giving laboratories both reliability and efficiency for demanding testing schedules.
All of these systems are built to support continuous random-access loading and ensure complete traceability of every sample and reagent through integrated barcoding. They also connect seamlessly with laboratory information systems (LIS) via bidirectional data transfer, enabling secure, standardized, and efficient result reporting.
By adopting EUROIMMUN ChLIA, laboratories benefit from a system that reduces hands-on time, accelerates turnaround, and delivers consistent quality. Reagents are optimized for long shelf life and stable performance, while the use of barcoded consumables ensures error-free sample management. Calibration requirements are minimized by stored master curves, allowing laboratories to focus resources on patient testing rather than frequent recalibration.
EUROIMMUN ChLIA combines the accuracy of immunodiagnostics with the speed of chemiluminescence, offering laboratories a future-proof solution for routine and specialized testing. By delivering high sensitivity, reproducibility, and flexibility across multiple diagnostic areas, ChLIA ensures that clinicians and patients receive results they can trust.
With the dedicated support of Southern Medical Supplies Limited, laboratories in the Caribbean have access not only to EUROIMMUN’s world-class assays and analyzers but also to expert training, technical service, and customer care. This partnership ensures smooth implementation, reliable performance, and long-term success for every laboratory adopting EUROIMMUN ChLIA.
👉 Available now from Southern Medical Supplies Limited — your trusted partner for EUROIMMUN ChLIA automation and diagnostics in the Caribbean.
With over three decades of regional expertise, SMSL is more than a supplier—we are your partner in healthcare innovation. By combining trusted global brands with unmatched local support, we deliver solutions that improve outcomes, reduce risks, and empower healthcare professionals to perform at their very best.
